Water Island Capital’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
Water Island Capital's INZY Position: Q3 2025 in Review
Water Island Capital sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 201,776 shares — an estimated $807K sold.
Water Island Capital first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $807K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.
- Water Island Capital reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
- Water Island Capital sold 201,776 Inozyme Pharma shares in Q3 2025, an estimated $807K.
- Water Island Capital first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
- Water Island Capital's Inozyme Pharma position peaked at $807K in Q2 2025.
- 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.
Based on Water Island Capital's 13F filing for Q3 2025, filed 14 Nov 2025.